Impact of distance from implant center on mechanical circulatory device patient outcomes.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 18 08 2020
revised: 15 10 2020
accepted: 26 10 2020
pubmed: 9 1 2021
medline: 15 5 2021
entrez: 8 1 2021
Statut: ppublish

Résumé

Patients on left ventricular assist device (LVAD) support receive extensive care and education before discharge home. We investigated the impact of patient's residential distance from LVAD implantation center on outcomes and survival. A total of 214 patients received a LVAD between 2006 and 2018 at our institution. Patient's residential distance from the LVAD implantation center, LVAD complications, hospitalization, and death were recorded. Patients were divided into two groups: patients living less than or equal to 100 miles (Group 1), patients living more than 100 (Group 2). A total of 106 patients were assigned to Group 1 and 108 patients were assigned to Group 2. Destination therapy was intended in 20% of patients in Group 1 and 34% in Group 2 (p = .023). Mean length of stay was 13 ± 9 days for Group 1 and 21 ± 12 for Group 2 (p < .001). Major postoperative complications were unplanned readmissions due to infections (9% and 12%), gastrointenstinal bleeding (15% and 14%), cerebrovascular accidents (6% and 7.4%), and acute kidney injury (5% and 2%), respectively for Group 1 and Group 2. There was no difference in major complications (all p > .05) and survival between patients in both groups (p > .05). Distance from implanting center had no impact on adverse outcomes after LVAD implantation. There was a significant increase in hospital stay for patients who live far from the implanting center, suggesting that distance should not be a contraindication when considering patients for LVAD therapy, but plans should be made for prolonged hospital stay or extended local stay near the hospital for close follow-up.

Identifiants

pubmed: 33415793
doi: 10.1111/jocs.15201
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

801-805

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56-e528.
Gustafsson, Rogers. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail. 2017;19(5):595-602.
Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC, Colombo PC. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017;376:440-450.
Brinkley MD, DeNofrio D, Ruthazer R, et al. Outcomes after continuous-flow left ventricular assist device implantation as destination therapy at transplant versus nontransplant centers. Circulation: Heart Failure. 2018;11(3):e004384.
Sajgalik P, Grupper A, Edwards BS, Daly RC, Kara T, Schirger JA. Current status of Left ventricular assist device therapy. Mayo Clin Proceed. 2016;91(7):927-940.
Jindal M, Zheng C, Quadri HS, et al. Why do long-distance travelers have improved pancreatectomy outcomes? J Am Coll Surg. 2017;225(2):216-225.
Vetterlein MW, Löppenberg B, Karabon P, et al. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer. Cancer. 2017;123(17):3241-3252.
Xu Y, Steckle S, Lui A, et al. Effect of proximity to specialty care on outcomes for biliary cancers: a population-based retrospective cohort study. CMAJ Open. 2019;28(71):E131-E139.
Abou-Nassar KE, Kim HT, Blossom J, et al. The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012;18(5):708-715.
Kelly C, Hulme C, Farragher T, Clarke G. Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review. BMJ Open. 2016;24(11):e013059.
Etzioni DA, Fowl RJ, Wasif N, Donohue JH, Cima RR. Distance bias and surgical outcomes. Med Care. 2013;51(3):238-244.
Murray MA, Osaki S, Edwards NM, et al. Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapy. Interact Cardiovasc Thorac Surg. 2009;8(1):84-88.
Stitzenberg KB, Chang Y, Smith AB, Nielsen ME. Exploring the burden of inpatient readmissions after major cancer surgery. J Clin Oncol. 2015;33(5):455-464.
Hawkins RB, Byler M, Fonner C, Kron I, Yarboro L, Speir A. Travel distance and regional access to cardiac valve surgery. J Card Surg. 2019;34:1044-1048.
Tsuang WM, Arrigain S, Lopez R, Snair M, Budev M, Schold JD. Patient travel distance and post lung transplant survival in the United States: a cohort study. Transplantation. 2020;104:2365-2372.
Chou Sh, Deily ME, Li S. Travel distance and health outcomes for scheduled surger. Med Care. 2014;52(3):250-257.

Auteurs

Entela B Lushaj (EB)

Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Amy Fiedler (A)

Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Malcolm DeCamp (M)

Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Chan J Park (CJ)

Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Ravi Dhingra (R)

Division of Cardiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Jason Smith (J)

Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH